| TVTXTravere Therapeutics, Inc. | Sep 17, 20269:33 PM ET | Sep 15, 2026 | Inrig JulaEVP, Head of R&D & CMO | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −44.67K | $62.341 | −$2.79M | 100.49K | −30.8% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | May 6, 2026 | May 4 – May 6, 2026 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −22.49K | $45.145 | −$1.02M | 113.24K | −16.6% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Apr 15, 2026 | Apr 14 – Apr 15, 2026 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −8.23K | $42.0141 | −$345.9K | 111.47K | −6.9% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 5, 2026 | Feb 4, 2026 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −1.78K | $32.2065 | −$57.3K | 105.71K | −1.7% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 3, 2026 | Feb 3, 2026 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −6.96K | $32.12 | −$223.43K | 107.49K | −6.1% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 7, 2026 | Jan 5 – Jan 6, 2026 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.48K | $39.7433 | −$98.4K | 86.31K | −2.8% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Dec 29, 2025 | Dec 24, 2025 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −15K | $42.00 | −$630K | 88.79K | −14.5% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Jul 2, 2025 | Jul 1, 2025 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −815 | $14.65 | −$11.94K | 88.79K | −0.9% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 12, 2025 | Feb 12, 2025 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.57K | $23.53 | −$60.43K | 89.6K | −2.8% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Feb 4, 2025 | Feb 3 – Feb 4, 2025 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −5.27K | $20.118 | −$106.08K | 84.17K | −5.9% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Jan 6, 2025 | Jan 3 – Jan 6, 2025 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.51K | $19.0403 | −$47.72K | 59.44K | −4.0% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Sep 10, 2024 | Sep 10, 2024 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −684 | $12.98 | −$8.88K | 61.95K | −1.1% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Sep 9, 2024 | Sep 9, 2024 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.19K | $11.52 | −$25.24K | 62.63K | −3.4% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Feb 2, 2024 | Feb 1, 2024 | Inrig JulaCHIEF MEDICAL OFFICER | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.17K | $8.53 | −$18.54K | 58.07K | −3.6% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 5, 2024 | Jan 3 – Jan 4, 2024 | Inrig JulaChief Medical Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.51K | $9.4256 | −$23.65K | 35.25K | −6.6% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 6, 2023 | Jan 4 – Jan 5, 2023 | Inrig JulaChief Medical Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.49K | $20.75 | −$51.73K | 17.51K | −12.5% | SEC↗ |
